InvestLog
PLYX Polaryx Therapeutics, Inc. Common Stock logo

PLYX Polaryx Therapeutics, Inc. Common Stock

Healthcare
$3.60-8.63%ClosedMarket Cap: $170.4M

As of 2026-05-25

Valuation

P/E (TTM)

—

PEG

—

P/B

68.32

P/S

0.00

EV/EBITDA

-35.40

DCF Value

$0.10

FCF Yield

-2.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-166.1%

ROA

-185.0%

ROIC

-190.0%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

PeriodRevenueGross MarginOperating IncomeNet IncomeEPSDividend
Q1 null$0.00NaN%$-2.0M$-2.5M$——
Q4 null$0.00NaN%$-911.0K$-1.5M$——
FY null$0.00NaN%$-7.8M$-9.0M$——
Q3 null$0.00NaN%$-974.0K$-1.4M$——
Q2 null$0.00NaN%$-884.0K$-1.0M$——
Q1 null$0.00NaN%$-5.1M$-5.1M$——
Q4 null$0.00NaN%$-723.0K$-723.0K$——
FY null$0.00NaN%$-4.4M$-30.4M$——
Q3 null$0.00NaN%$-771.0K$-771.0K$——
FY null$0.00NaN%$-3.8M$-3.8M$——